SFX by Ex Libris Inc.

Title:	Combining high selectivity of replicationviaCXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer
Source:	International Journal of Cancer [0020-7136] Stoff Khalili, Mariam yr:2006

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hingorani, M. "Combining Radiation and Cancer Gene Therapy: A Potential Marriage of Physical and Biological Targeting?" Current cancer drug targets 7.4 (2007): 389-409.
description	2.	McDonald, Cari J J. "A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer." Breast cancer research and treatment 99.2 (2006): 177-84.
description	3.	Tanaka, H. "siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells." International journal of cancer 118.7 (2006): 1680-91.
description	4.	Cattaneo, R. "Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded." Nature reviews. Microbiology 6.7 (2008): 529-40.
description	5.	Tang, Z. "Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells." Bone 38.2 (2006): 181-198.
description	6.	Lee, P. "Oncolytic reovirus effectively targets breast cancer stem cells." Molecular therapy 17.6 (2009): 972-9.
description	7.	Wang, R. "Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo." Breast Cancer Research and Treatment 117.1 (2009): 45-54.
description	8.	Nawa, A. "Non-engineered, naturally oncolytic herpes simplex virus HSV1 HF-10: applications for cancer gene therapy." Current gene therapy 8.3 (2008): 208-21.
description	9.	Collins, SA A. "Viral vectors in cancer immunotherapy: Which vector for which strategy?" Current gene therapy 8.2 (2008): 66-78.
description	10.	Marx, C. "Validated High-Throughput Screening of Drug-Like Small Molecules for Inhibitors of ErbB2 Transcription." Assay and drug development technologies 4.3 (2006): 273-284.
description	11.	Galanis, Ianko J. "Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model." Breast Cancer Research and Treatment 122.3 (2009): 745-754.
description	12.	Maeda, M. "Design and synthesis of a peptide-PEG transporter tool for carrying adenovirus vector into cells." Bioorganic & medicinal chemistry letters 15.3 (2005): 621-624.
description	13.	Kierbel, J. "The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization." Molecular biology of the cell 16.5 (2005): 2577-85.
description	14.	Zhang, Kai-Xin X. "Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor." Molecular cancer research 2.4 (2004): 242-55.
description	15.	Kim, Eun-Sook S. "TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells." International journal of oncology 25.5 (2004): 1375-82.
description	16.	Gravdal, K. "A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer." Clinical cancer research 13.23 (2007): 7003-11.
description	17.	Yang, S. "A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus." Gene therapy 14.8 (2007): 638-47.
description	18.	Levin, B. "Population and evolutionary dynamics of phage therapy." Nature reviews. Microbiology 2.2 (2004): 166-173.
description	19.	Ahmed, Z. "In vitro evaluation of a 'stealth' adenoviral vector for targeted gene delivery to adult mammalian neurones." Journal of Gene Medicine 11.4 (2009): 335-344.
description	20.	Anne, P. "Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial." The lancet oncology 9.6 (2008): 533-542.